Literature DB >> 20009359

Expression of toll-like receptors in the pancreas of recent-onset fulminant type 1 diabetes.

Saeko Shibasaki1, Akihisa Imagawa, Sisko Tauriainen, Morio Iino, Maarit Oikarinen, Hitoshi Abiru, Keiji Tamaki, Hiroaki Seino, Katsuhiro Nishi, Izumi Takase, Yoshikatsu Okada, Sae Uno, Yuko Murase-Mishiba, Jungo Terasaki, Hideichi Makino, Iichiro Shimomura, Heikki Hyöty, Toshiaki Hanafusa.   

Abstract

Fulminant type 1 diabetes, established in 2000, is defined as a novel subtype of diabetes mellitus that results from remarkably acute and almost complete destruction of pancreatic beta cells at the disease onset. In this study, we aimed to clarify the pathogenesis of fulminant type 1 diabetes with special reference to insulitis and viral infection. We examined pancreatic autopsy samples from three patients who had died soon after the onset of disease and analyzed these by immunohistochemistry and in situ-hybridization. The results were that both beta and alpha cell areas were significantly decreased in comparison with those of normal controls. Mean beta cell area of the patients just after the onset was only 0.00256 % while that of normal control was 1.745 %. Macrophages and T cells-but no natural killer cells-had infiltrated the islets and the exocrine pancreas. Although both of them had massively infiltrated, macrophages dominated islet infiltration and were detected in 92.6 % of the patients' islets. Toll-like receptor (TLR) 3, a sensor of viral components, was detected in 84.7+/- 7.0 % of T cells and 62.7+/- 32.3 % of macrophages (mean+/- SD) in all three patients. TLR7 and TLR9 were also detected in the pancreas of all three patients. Enterovirus RNA was detected in beta-cell positive islets in one of the three patients by in situ-hybridization. In conclusion, our results suggest that macrophage-dominated insulitis rather than T cell autoimmunity contributes to beta cell destruction in fulminant type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20009359     DOI: 10.1507/endocrj.k09e-291

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  27 in total

Review 1.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

Review 2.  Enterovirus and type 1 diabetes: What is the matter?

Authors:  Carla Sanchez Bergamin; Sergio Atala Dib
Journal:  World J Diabetes       Date:  2015-06-25

Review 3.  Epigenetic regulation of Toll-like receptors and its roles in type 1 diabetes.

Authors:  Zhiguo Xie; Gan Huang; Zhen Wang; Shuoming Luo; Peilin Zheng; Zhiguang Zhou
Journal:  J Mol Med (Berl)       Date:  2018-07-12       Impact factor: 4.599

4.  Dysregulated TLR3-dependent signaling and innate immune activation in superoxide-deficient macrophages from nonobese diabetic mice.

Authors:  Maria C Seleme; Weiqi Lei; Ashley R Burg; Kah Yong Goh; Allison Metz; Chad Steele; Hubert M Tse
Journal:  Free Radic Biol Med       Date:  2012-02-04       Impact factor: 7.376

Review 5.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: the enterovirus link to type 1 diabetes: critical review of human studies.

Authors:  L C Stene; M Rewers
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

6.  Toll-like receptor 7 stimulation promotes autoimmune diabetes in the NOD mouse.

Authors:  A S Lee; M Ghoreishi; W K Cheng; T-Y E Chang; Y Q Zhang; J P Dutz
Journal:  Diabetologia       Date:  2011-02-22       Impact factor: 10.122

7.  Low programmed cell death-1 (PD-1) expression in peripheral CD4(+) T cells in Japanese patients with autoimmune type 1 diabetes.

Authors:  R Fujisawa; F Haseda; C Tsutsumi; Y Hiromine; S Noso; Y Kawabata; S Mitsui; J Terasaki; H Ikegami; A Imagawa; T Hanafusa
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 8.  Virus infections and type 1 diabetes risk.

Authors:  Merja Roivainen; Karin Klingel
Journal:  Curr Diab Rep       Date:  2010-10       Impact factor: 4.810

9.  Foxp3-independent mechanism by which TGF-β controls peripheral T cell tolerance.

Authors:  Soyoung A Oh; Ming Liu; Briana G Nixon; Davina Kang; Ahmed Toure; Michael Bivona; Ming O Li
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-21       Impact factor: 11.205

10.  CD4⁺ CD45RA⁻ FoxP3high activated regulatory T cells are functionally impaired and related to residual insulin-secreting capacity in patients with type 1 diabetes.

Authors:  F Haseda; A Imagawa; Y Murase-Mishiba; J Terasaki; T Hanafusa
Journal:  Clin Exp Immunol       Date:  2013-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.